ADVERSE REACTIONS TO ANTITUBERCULOSIS DRUGS AND THE FACTORS CONTRIBUTING TO THEIR DEVELOPMENT IN PATIENTS WITH LONG-STANDING PULMONARY TUBERCULOSIS

Download full text PDF
Issue: 
11
Year: 
2016

A. Kondrya (1); A. Mordyk (1), MD; S. Rudenko (2), Candidate of Medical Sciences 1 -Omsk State Medical University 2 -Clinical Tuberculosis Dispensary Four, Omsk

The investigation enrolled 214 patients with long-standing pulmonary tuberculosis that was complicated by adverse reactions of chemotherapy (CT) in 78.0% of cases. The adverse reactions occurring during CT in the patients with longstanding tuberculosis prevent their cure.
Keywords: 
phthisiology
tuberculosis
long-standing tuberculosis
chemotherapy
multidrug resistance
antituberculosis drugs
adverse reactions
clinical cure

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sterlikov S.A., Smerdin S.V., Radina T.S. Polnota registratsii sluchaev povtornogo lechenija bol'nyh tuberkulezom i ego rezul'taty // Tuberkulez i bolezni legkih. – 2014; 12: 35–9.
  2. Mishin V.Ju., Chukanov V.I., Grigor'ev Ju.G. Pobochnoe dejstvie protivotuberkuleznyh preparatov pri standartnyh i individualizirovannyh rezhimah himioterapii / M.: Komp'juterburg, 2004; s. 208.
  3. Mordyk A.V., Kondrja A.V., Gaponenko G.E. Chastota neblagoprijatnyh pobochnyh reaktsij na protivotuberkuleznye preparaty u vpervye vyjavlennyh bol'nyh tuberkulezom organov dyhanija starshe 18 let i faktory, vlijajuschie na ih razvitie // Tuberkulez i bolezni legkih. – 2010; 87 (2): 44–8.
  4. O sovershenstvovanii protivotuberkuleznyh meroprijatij v Rossijskoj Federatsii: Prikaz Minzdrava RF ot 21.03.2003 №109 // Konsul'tantPljus: sprav.-pravovaja sistema. – Rezhim dostupa: http://www.consultant.ru/
  5. Nechaeva O.B., Sterlikov S.A., Hurieva N.B. Tselevye indikatory i pokazateli gosudarstvennoj programmy razvitija zdravoohranenija Rossii do 2020 g. // Tuberkulez i bolezni legkih. – 2014; 12: 25–34.
  6. Bereznikov A.V., Mordyk A.V., Lysov A.V. i dr. Antibiotikassotsiirovannye diarei vo ftiziatricheskoj praktike: standartizatsija diagnostiki, lechenija, profilaktiki, ekspertiza kachestva meditsinskoj pomoschi // Tuberkulez i bolezni legkih. – 2008; 85 (7): 47–50.
  7. Mordyk A.V. Chastota i patogenez neblagoprijatnyh pobochnyh reaktsij na protivotuberkuleznye preparaty // Vestn. sovremennoj klin. meditsiny. – 2010; 3 (1): 16–21.
  8. Stepanova N.A., Strel'tsova E.N., Galimzjanov H.M. i dr. Nezhelatel'nye pobochnye effekty na protivotuberkuleznye preparaty u vpervye vyjavlennyh bol'nyh tuberkulezom legkih // Astrahanskij med. zhurn. – 2014; 9 (4): 66–71.
  9. Strelis A.K., Schegortseva D.Ju., Bujnova L.N. Pobochnye effekty pri lechenii tuberkuleza s mnozhestvennoj lekarstvennoj ustojchivost'ju M. tuberculosis. Materialy VII Ross. s'ezda ftiziatrov «Tuberkulez segodnja», Moskva, 3–5 ijunja 2003; s. 263.
  10. Bereznikov A.V., Mordyk A.V., Konev V.P. i dr. Lekarstvennye porazhenija pecheni s upornym techeniem u bol'nyh tuberkulezom // Tuberkulez i bolezni legkih. – 2010; 87 (4): 43–6.
  11. Lepshina S.M., Serdjuk O.V., Tischenko E.V. Pobochnye reaktsii na protivotuberkuleznye preparaty u bol'nyh mul'tirezistentnym tuberkulezom legkih // Vestnik neotlozhnoj i vosstanovitel'noj meditsiny. – 2014; 15 (2): 219–21.
  12. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju tuberkuleza organov dyhanija / M., Tver': Triada, 2014; s. 56.
  13. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju tuberkuleza organov dyhanija s mnozhestvennoj i shirokoj lekarstvennoj ustojchivost'ju vozbuditelja / M., Tver': Triada, 2014; s. 72.
  14. Astahova A.V., Lepahin V.K. Neblagoprijatnye pobochnye reaktsii i kontrol' bezopasnosti lekarstv: Rukovodstvo po farmakonadzoru / M.: Kogito-Tsentr, 2004; s. 200.
  15. Halafjan A.A. STATISTICA 6.0. Statisticheskij analiz dannyh. 3-e izd. Uchebnik / M.: Binom-Press, 2008; s. 512.